Other names: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; MF; Myeloid metaplasia; Primary myelofibrosis; Secondary myelofibrosis
Myelofibrosis is a disorder of the bone marrow, in which the marrow is replaced by scar (fibrous) tissue.
Other names: Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; MF; Myeloid metaplasia; Primary myelofibrosis; Secondary myelofibrosis
Myelofibrosis is a disorder of the bone marrow, in which the marrow is replaced by scar (fibrous) tissue.
| Name | Drug Class | Updated |
|---|---|---|
| Ruxolitinib (systemic) (monograph) | Drugs | 14-Aug-2023 |
| Ruxolitinib | Multikinase inhibitors | 14-Aug-2023 |
| Pacritinib | Multikinase inhibitors | 11-Aug-2023 |
| Fedratinib | Multikinase inhibitors | 11-Aug-2023 |
| Vonjo | Multikinase inhibitors | 14-Jul-2023 |
| Inrebic | Multikinase inhibitors | 13-Jul-2023 |
| Jakafi | Multikinase inhibitors | 10-Jul-2023 |
| Ojjaara | Drugs | 18-Sep-2023 |
| Pacritinib (systemic) (monograph) | Drugs | 26-Sep-2023 |
| Fedratinib (systemic) (monograph) | Drugs | 12-Oct-2023 |